1. Home
  2. SHCO vs ADPT Comparison

SHCO vs ADPT Comparison

Compare SHCO & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHCO
  • ADPT
  • Stock Information
  • Founded
  • SHCO 1995
  • ADPT 2009
  • Country
  • SHCO United Kingdom
  • ADPT United States
  • Employees
  • SHCO N/A
  • ADPT N/A
  • Industry
  • SHCO Hotels/Resorts
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SHCO Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • SHCO Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • SHCO 1.0B
  • ADPT 1.1B
  • IPO Year
  • SHCO 2021
  • ADPT 2019
  • Fundamental
  • Price
  • SHCO $5.96
  • ADPT $9.03
  • Analyst Decision
  • SHCO Strong Buy
  • ADPT Buy
  • Analyst Count
  • SHCO 3
  • ADPT 6
  • Target Price
  • SHCO $7.50
  • ADPT $9.83
  • AVG Volume (30 Days)
  • SHCO 234.3K
  • ADPT 3.0M
  • Earning Date
  • SHCO 05-09-2025
  • ADPT 05-01-2025
  • Dividend Yield
  • SHCO N/A
  • ADPT N/A
  • EPS Growth
  • SHCO N/A
  • ADPT N/A
  • EPS
  • SHCO N/A
  • ADPT N/A
  • Revenue
  • SHCO $1,224,734,000.00
  • ADPT $189,527,000.00
  • Revenue This Year
  • SHCO $8.74
  • ADPT $21.20
  • Revenue Next Year
  • SHCO $5.04
  • ADPT $21.99
  • P/E Ratio
  • SHCO N/A
  • ADPT N/A
  • Revenue Growth
  • SHCO 8.21
  • ADPT 8.61
  • 52 Week Low
  • SHCO $4.43
  • ADPT $2.99
  • 52 Week High
  • SHCO $8.47
  • ADPT $10.28
  • Technical
  • Relative Strength Index (RSI)
  • SHCO 50.40
  • ADPT 57.82
  • Support Level
  • SHCO $5.99
  • ADPT $8.38
  • Resistance Level
  • SHCO $6.58
  • ADPT $9.51
  • Average True Range (ATR)
  • SHCO 0.33
  • ADPT 0.66
  • MACD
  • SHCO 0.08
  • ADPT 0.16
  • Stochastic Oscillator
  • SHCO 54.80
  • ADPT 63.02

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: